Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor. Issue 4 (16th February 2018)

• Record Type: Journal Article
• Authors: Basu, Debapriya; Hu, Yunying; Huggins, Lesley-Ann; Mullick, Adam E.; Graham, Mark J.; Wietecha, Tomasz; Barnhart, Shelley; Mogul, Allison; Pfeiffer, Katharina; Zirlik, Andreas; Fisher, Edward A.; Bornfeldt, Karin E.; Willecke, Florian; Goldberg, Ira J.
• Is Part Of: Circulation research. Volume 122:Issue 4(2018)
• Publication Date: 2018-02-16
• Subjects: cholesterol, LDL -- lipids -- lipoprotein -- macrophage -- metabolism; Cardiovascular system -- Periodicals; Blood -- Circulation -- Periodicals; Blood Circulation; Cardiovascular System; Vascular Diseases; Sang -- Circulation -- Périodiques; Appareil cardiovasculaire -- Périodiques; 612.1
• DOI: 10.1161/CIRCRESAHA.117.311361
• Languages: English
• ISSNs: 0009-7330

Abstract

Abstract : Rationale: : Animal models have been used to explore factors that regulate atherosclerosis. More recently, they have been used to study the factors that promote loss of macrophages and reduction in lesion size after lowering of plasma cholesterol levels. However, current animal models of atherosclerosis regression require challenging surgeries, time-consuming breeding strategies, and methods that block liver lipoprotein secretion. Objective: : We sought to develop a more direct or time-effective method to create and then reverse hypercholesterolemia and atherosclerosis via transient knockdown of the hepatic LDLR (low-density lipoprotein receptor) followed by its rapid restoration. Methods and Results: : We used antisense oligonucleotides directed to LDLR mRNA to create hypercholesterolemia in wild-type C57BL/6 mice fed an atherogenic diet. This led to the development of lesions in the aortic root, aortic arch, and brachiocephalic artery. Use of a sense oligonucleotide replicating the targeted sequence region of the LDLR mRNA rapidly reduced circulating cholesterol levels because of recovery of hepatic LDLR expression. This led to a decrease in macrophages within the aortic root plaques and brachiocephalic artery, that is, regression of inflammatory cell content, after a period of 2 to 3 weeks. Conclusions: : We have developed an inducible and reversible hepatic LDLR knockdown mouse model of atherosclerosis regression. Although cholesterol reduction decreased early en face lesions in the aortic arches, macrophage area was reduced in both early and late lesions within the aortic sinus after reversal of hypercholesterolemia. Our model circumvents many of the challenges associated with current mouse models of regression. The use of this technology will potentially expedite studies of atherosclerosis and regression without use of mice with genetic defects in lipid metabolism. Abstract : Supplemental Digital Content is available in the text.